Last reviewed · How we verify

Autologous BMDC implantation at the venous ulcer — Competitive Intelligence Brief

Autologous BMDC implantation at the venous ulcer (Autologous BMDC implantation at the venous ulcer) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 1 Biologic Live · refreshed every 30 min

Target snapshot

Autologous BMDC implantation at the venous ulcer (Autologous BMDC implantation at the venous ulcer) — Hospital de Clínicas Dr. Manuel Quintela.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Autologous BMDC implantation at the venous ulcer TARGET Autologous BMDC implantation at the venous ulcer Hospital de Clínicas Dr. Manuel Quintela phase 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Autologous BMDC implantation at the venous ulcer — Competitive Intelligence Brief. https://druglandscape.com/ci/autologous-bmdc-implantation-at-the-venous-ulcer. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: